Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 11/2014

01.11.2014 | Article

Fecal microbiome analysis as a diagnostic test for diverticulitis

verfasst von: L. Daniels, A. E. Budding, N. de Korte, A. Eck, J. A. Bogaards, H. B. Stockmann, E. C. Consten, P. H. Savelkoul, M. A. Boermeester

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Disease-specific variations in intestinal microbiome composition have been found for a number of intestinal disorders, but little is known about diverticulitis. The purpose of this study was to compare the fecal microbiota of diverticulitis patients with control subjects from a general gastroenterological practice and to investigate the feasibility of predictive diagnostics based on complex microbiota data. Thirty-one patients with computed tomography (CT)-proven left-sided uncomplicated acute diverticulitis were included and compared with 25 control subjects evaluated for a range of gastrointestinal indications. A high-throughput polymerase chain reaction (PCR)-based profiling technique (IS-pro) was performed on DNA isolates from baseline fecal samples. Differences in bacterial phylum abundance and diversity (Shannon index) of the resulting profiles were assessed by conventional statistics. Dissimilarity in microbiome composition was analyzed with principal coordinate analysis (PCoA) based on cosine distance measures. To develop a prediction model for the diagnosis of diverticulitis, we used cross-validated partial least squares discriminant analysis (PLS-DA). Firmicutes/Bacteroidetes ratios and Proteobacteria load were comparable among patients and controls (p = 0.20). The Shannon index indicated a higher diversity in diverticulitis for Proteobacteria (p < 0.00002) and all phyla combined (p = 0.002). PCoA based on Proteobacteria profiles resulted in visually separate clusters of patients and controls. The diagnostic accuracy of the cross-validated PLS-DA regression model was 84 %. The most discriminative species derived largely from the family Enterobacteriaceae. Diverticulitis patients have a higher diversity of fecal microbiota than controls from a mixed population, with the phylum Proteobacteria defining the difference. The analysis of intestinal microbiota offers a novel way to diagnose diverticulitis.
Literatur
1.
Zurück zum Zitat Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F et al (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229–241PubMedCrossRef Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F et al (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229–241PubMedCrossRef
2.
Zurück zum Zitat Bäckhed F, Ding H, Wang T et al (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101:15718–15723PubMedCrossRefPubMedCentral Bäckhed F, Ding H, Wang T et al (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101:15718–15723PubMedCrossRefPubMedCentral
3.
Zurück zum Zitat Stappenbeck TS, Hooper LV, Gordon JI (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 99:15451–15455PubMedCrossRefPubMedCentral Stappenbeck TS, Hooper LV, Gordon JI (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 99:15451–15455PubMedCrossRefPubMedCentral
5.
Zurück zum Zitat Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10:159–169PubMedCrossRef Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10:159–169PubMedCrossRef
6.
Zurück zum Zitat Clarridge JE 3rd (2004) Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 17:840–862PubMedCrossRefPubMedCentral Clarridge JE 3rd (2004) Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 17:840–862PubMedCrossRefPubMedCentral
7.
Zurück zum Zitat Budding AE, Grasman ME, Lin F et al (2010) IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota. FASEB J 24:4556–4564PubMedCrossRef Budding AE, Grasman ME, Lin F et al (2010) IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota. FASEB J 24:4556–4564PubMedCrossRef
9.
Zurück zum Zitat Dethlefsen L, Huse S, Sogin ML et al (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280PubMedCrossRefPubMedCentral Dethlefsen L, Huse S, Sogin ML et al (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280PubMedCrossRefPubMedCentral
10.
Zurück zum Zitat Wang X, Heazlewood SP, Krause DO et al (2003) Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 95:508–520PubMedCrossRef Wang X, Heazlewood SP, Krause DO et al (2003) Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 95:508–520PubMedCrossRef
11.
Zurück zum Zitat Zoetendal EG, Akkermans ADL, de Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64:3854–3859PubMedPubMedCentral Zoetendal EG, Akkermans ADL, de Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64:3854–3859PubMedPubMedCentral
13.
Zurück zum Zitat Frank DN, St Amand AL, Feldman RA et al (2007) Molecular–phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780–13785PubMedCrossRefPubMedCentral Frank DN, St Amand AL, Feldman RA et al (2007) Molecular–phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780–13785PubMedCrossRefPubMedCentral
14.
Zurück zum Zitat Zoetendal EG, von Wright A, Vilpponen-Salmela T et al (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68:3401–3407PubMedCrossRefPubMedCentral Zoetendal EG, von Wright A, Vilpponen-Salmela T et al (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68:3401–3407PubMedCrossRefPubMedCentral
15.
Zurück zum Zitat Sokol H, Pigneur B, Watterlot L et al (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105:16731–16736PubMedCrossRefPubMedCentral Sokol H, Pigneur B, Watterlot L et al (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105:16731–16736PubMedCrossRefPubMedCentral
16.
Zurück zum Zitat Swidsinski A, Loening-Baucke V, Vaneechoutte M et al (2008) Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 14:147–161PubMedCrossRef Swidsinski A, Loening-Baucke V, Vaneechoutte M et al (2008) Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 14:147–161PubMedCrossRef
17.
Zurück zum Zitat Ley RE, Turnbaugh PJ, Klein S et al (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444:1022–1023PubMedCrossRef Ley RE, Turnbaugh PJ, Klein S et al (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444:1022–1023PubMedCrossRef
18.
Zurück zum Zitat Turnbaugh PJ, Ley RE, Mahowald MA et al (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031PubMedCrossRef Turnbaugh PJ, Ley RE, Mahowald MA et al (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031PubMedCrossRef
19.
Zurück zum Zitat Swidsinski A, Dörffel Y, Loening-Baucke V et al (2011) Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60:34–40PubMedCrossRef Swidsinski A, Dörffel Y, Loening-Baucke V et al (2011) Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60:34–40PubMedCrossRef
20.
Zurück zum Zitat Floch MH (2006) A hypothesis: is diverticulitis a type of inflammatory bowel disease? J Clin Gastroenterol 40(Suppl 3):S121–S125PubMedCrossRef Floch MH (2006) A hypothesis: is diverticulitis a type of inflammatory bowel disease? J Clin Gastroenterol 40(Suppl 3):S121–S125PubMedCrossRef
22.
Zurück zum Zitat Unlü C, de Korte N, Daniels L et al; Dutch Diverticular Disease 3D Collaborative Study Group (2010) A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial). BMC Surg 10:23PubMedCrossRefPubMedCentral Unlü C, de Korte N, Daniels L et al; Dutch Diverticular Disease 3D Collaborative Study Group (2010) A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial). BMC Surg 10:23PubMedCrossRefPubMedCentral
23.
Zurück zum Zitat Wasvary H, Turfah F, Kadro O et al (1999) Same hospitalization resection for acute diverticulitis. Am Surg 65:632–635PubMed Wasvary H, Turfah F, Kadro O et al (1999) Same hospitalization resection for acute diverticulitis. Am Surg 65:632–635PubMed
25.
Zurück zum Zitat Mendeloff AI (1986) Thoughts on the epidemiology of diverticular disease. Clin Gastroenterol 15:855–877PubMed Mendeloff AI (1986) Thoughts on the epidemiology of diverticular disease. Clin Gastroenterol 15:855–877PubMed
26.
Zurück zum Zitat Syed SA, Loesche WJ (1972) Survival of human dental plaque flora in various transport media. Appl Microbiol 24:638–644PubMedPubMedCentral Syed SA, Loesche WJ (1972) Survival of human dental plaque flora in various transport media. Appl Microbiol 24:638–644PubMedPubMedCentral
27.
28.
Zurück zum Zitat Rajilić-Stojanović M, Biagi E, Heilig HG et al (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141:1792–1801PubMedCrossRef Rajilić-Stojanović M, Biagi E, Heilig HG et al (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141:1792–1801PubMedCrossRef
29.
Zurück zum Zitat Hastie T, Tibshirani R, Friedman J (2001) The elements of statistical learning. Springer, New YorkCrossRef Hastie T, Tibshirani R, Friedman J (2001) The elements of statistical learning. Springer, New YorkCrossRef
30.
Zurück zum Zitat Pérez-Enciso M, Tenenhaus M (2003) Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum Genet 112:581–592PubMed Pérez-Enciso M, Tenenhaus M (2003) Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum Genet 112:581–592PubMed
31.
Zurück zum Zitat Nguyen DV, Rocke DM (2002) Tumor classification by partial least squares using microarray gene expression data. Bioinformatics 18:39–50PubMedCrossRef Nguyen DV, Rocke DM (2002) Tumor classification by partial least squares using microarray gene expression data. Bioinformatics 18:39–50PubMedCrossRef
32.
Zurück zum Zitat Modlich O, Prisack HB, Munnes M et al (2005) Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures. J Transl Med 3:32PubMedCrossRefPubMedCentral Modlich O, Prisack HB, Munnes M et al (2005) Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures. J Transl Med 3:32PubMedCrossRefPubMedCentral
33.
Zurück zum Zitat Diaz SO, Barros AS, Goodfellow BJ et al (2013) Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes. J Proteome Res 12:2946–2957PubMedCrossRef Diaz SO, Barros AS, Goodfellow BJ et al (2013) Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes. J Proteome Res 12:2946–2957PubMedCrossRef
34.
Zurück zum Zitat Tap J, Mondot S, Levenez F et al (2009) Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11:2574–2584PubMedCrossRef Tap J, Mondot S, Levenez F et al (2009) Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11:2574–2584PubMedCrossRef
35.
Zurück zum Zitat Brook I, Frazier EH (2000) Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 49:827–830PubMed Brook I, Frazier EH (2000) Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 49:827–830PubMed
36.
Zurück zum Zitat Gueimonde M, Ouwehand A, Huhtinen H et al (2007) Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 13:3985–3989PubMedCrossRefPubMedCentral Gueimonde M, Ouwehand A, Huhtinen H et al (2007) Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 13:3985–3989PubMedCrossRefPubMedCentral
37.
Zurück zum Zitat de Korte N, Unlü C, Boermeester MA et al (2011) Use of antibiotics in uncomplicated diverticulitis. Br J Surg 98:761–767PubMedCrossRef de Korte N, Unlü C, Boermeester MA et al (2011) Use of antibiotics in uncomplicated diverticulitis. Br J Surg 98:761–767PubMedCrossRef
38.
Zurück zum Zitat Chabok A, Påhlman L, Hjern F et al; AVOD Study Group (2012) Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg 99:532–539PubMedCrossRef Chabok A, Påhlman L, Hjern F et al; AVOD Study Group (2012) Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg 99:532–539PubMedCrossRef
39.
Zurück zum Zitat Colecchia A, Vestito A, Pasqui F et al (2007) Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 13:264–269PubMedCrossRefPubMedCentral Colecchia A, Vestito A, Pasqui F et al (2007) Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 13:264–269PubMedCrossRefPubMedCentral
40.
Zurück zum Zitat Papi C, Ciaco A, Koch M et al (1992) Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Ital J Gastroenterol 24:452–456PubMed Papi C, Ciaco A, Koch M et al (1992) Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Ital J Gastroenterol 24:452–456PubMed
41.
Zurück zum Zitat Latella G, Pimpo MT, Sottili S et al (2003) Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 18:55–62PubMedCrossRef Latella G, Pimpo MT, Sottili S et al (2003) Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 18:55–62PubMedCrossRef
42.
Zurück zum Zitat Papi C, Ciaco A, Koch M et al (1995) Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 9:33–39PubMedCrossRef Papi C, Ciaco A, Koch M et al (1995) Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 9:33–39PubMedCrossRef
43.
Zurück zum Zitat Porta E, Germano A, Ferrieri A et al (1994) The natural history of diverticular disease of the colon: A role for antibiotics in preventing complications? A retrospective study. Riv Eur Sci Med Farmacol 16:33–39PubMed Porta E, Germano A, Ferrieri A et al (1994) The natural history of diverticular disease of the colon: A role for antibiotics in preventing complications? A retrospective study. Riv Eur Sci Med Farmacol 16:33–39PubMed
44.
Zurück zum Zitat Tursi A, Brandimarte G, Giorgetti GM et al (2007) Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis 22:1103–1108PubMedCrossRef Tursi A, Brandimarte G, Giorgetti GM et al (2007) Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis 22:1103–1108PubMedCrossRef
45.
Zurück zum Zitat Dughera L, Serra AM, Battaglia E et al (2004) Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension. Minerva Gastroenterol Dietol 50:149–153PubMed Dughera L, Serra AM, Battaglia E et al (2004) Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension. Minerva Gastroenterol Dietol 50:149–153PubMed
46.
Zurück zum Zitat Frič P, Zavoral M (2003) The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 15:313–315PubMedCrossRef Frič P, Zavoral M (2003) The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 15:313–315PubMedCrossRef
47.
Zurück zum Zitat Lamiki P, Tsuchiya J, Pathak S et al (2010) Probiotics in diverticular disease of the colon: an open label study. J Gastrointestin Liver Dis 19:31–36PubMed Lamiki P, Tsuchiya J, Pathak S et al (2010) Probiotics in diverticular disease of the colon: an open label study. J Gastrointestin Liver Dis 19:31–36PubMed
48.
Zurück zum Zitat Laméris W, van Randen A, van Gulik TM et al (2010) A clinical decision rule to establish the diagnosis of acute diverticulitis at the emergency department. Dis Colon Rectum 53:896–904PubMedCrossRef Laméris W, van Randen A, van Gulik TM et al (2010) A clinical decision rule to establish the diagnosis of acute diverticulitis at the emergency department. Dis Colon Rectum 53:896–904PubMedCrossRef
Metadaten
Titel
Fecal microbiome analysis as a diagnostic test for diverticulitis
verfasst von
L. Daniels
A. E. Budding
N. de Korte
A. Eck
J. A. Bogaards
H. B. Stockmann
E. C. Consten
P. H. Savelkoul
M. A. Boermeester
Publikationsdatum
01.11.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2014
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2162-3

Weitere Artikel der Ausgabe 11/2014

European Journal of Clinical Microbiology & Infectious Diseases 11/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.